Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
The Truth About HIV

Dr Chris van Tulleken explores the latest science around HIV, meeting health professionals, scientists, and individuals affected by it in the UK and South Africa.

Published
20 hours ago
From
BBC iPlayer (UK only, available until 24 June)
Life insurance policyholders with HIV urged to review life cover term

People with HIV who took out life insurance between 2009 and 2013 should review their policy, Unusual Risks has urged.

Published
24 May 2017
From
Professional Adviser
Unexpected side effects with generic abacavir – and potential for rare reactions to other generic ARVs

Several anecdotal reports of mouth ulcers have recently been reported in people switching to generic abacavir in the UK. This should highlight awareness of the potential of likely-rare new side effects, even when both formulations have been approved as bioequivalent.

Published
23 May 2017
From
HIV i-Base
Merck Receives CHMP Positive Opinion Recommending Approval of ISENTRESS® (raltegravir) 600 mg in the European Union

In adults and pediatric patients (weighing at least 40 kg), the recommended dosage is 1,200 mg (two 600 mg tablets) once daily for treatment-naïve patients or patients who are virologically suppressed on an initial regimen of ISENTRESS 400 mg twice daily.

Published
22 May 2017
From
Merck press release
CHMP recommends for approval generic version of Atripla

At its May meeting, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended for approval a generic version of Atripla – Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva (efavirenz/emtricitabine/tenofovir disoproxil) for the treatment of HIV infection.

Published
22 May 2017
From
EATG
Stock market models accurately predict changes in HIV over time

Stock market models accurately predict changes in HIV over timeHealioMathematical models that were originally developed to predict changes in stock prices accurately predicted changes in the properties of HIV, suggesting that such models could be used for the development of a future vaccine for HIV, according to data published in PLOS Biology.

Published
18 May 2017
From
Healio
Combining drug addiction treatment and perinatal HIV prevention leads to good outcomes in Kenya

An integrated programme offering medication-assisted drug addiction treatment and services aimed at preventing mother-to-child HIV transmission led to improved outcomes for opioid-dependent HIV-positive mothers and their babies, according

Published
18 May 2017
By
Liz Highleyman
The HIV story is not over - the spectre of anti-science threatens our advances

The life expectancy of people with HIV is now ‘near normal’, but complacency would be wrong.

Published
17 May 2017
From
The Guardian
Life expectancy now near-normal in people with CD4 counts over 350 a year after starting therapy

A large study of 88,504 people with HIV on antiretroviral therapy (ART), published in The Lancet HIV journal and reported widely in the news, has found substantial

Published
15 May 2017
By
Gus Cairns
Protease inhibitor drug suppresses HIV in semen more slowly than drugs from other classes

Protease inhibitors may not be the best class of drug for people newly diagnosed with HIV to start treatment with, if they wish to quickly

Published
12 May 2017
By
Gus Cairns
← First12345...442Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.